Cheryl Lynn Jaeger is named as a lobbyist on federal disclosure filings for 44 clients through Crossroads Strategies, LLC. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code and Budget/Appropriations.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| PROTON THERAPY CONSORTIUM | CROSSROADS STRATEGIES, LLC | Q3 2026 | Medicare/Medicaid |
| LATHAM & WATKINS LLP OBO PEDIATRIC ASSOCIATES | CROSSROADS STRATEGIES, LLC | Q3 2026 | Medicare/Medicaid |
| BROAD INSTITUTE | CROSSROADS STRATEGIES, LLC | Q3 2026 | Science/Technology, Defense, Medical/Disease Research/Clinical Labs |
| 3M COMPANY | CROSSROADS STRATEGIES, LLC | Q3 2026 | Taxation/Internal Revenue Code, Environment/Superfund, Consumer Issues/Safety/Products |
| SANOFI US SERVICES INC. | CROSSROADS STRATEGIES, LLC | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| NATIONAL MULTIPLE SCLEROSIS SOCIETY | CROSSROADS STRATEGIES, LLC | Q3 2026 | Taxation/Internal Revenue Code, Medicare/Medicaid, Health Issues |
| MARSH MCLENNAN | CROSSROADS STRATEGIES, LLC | Q3 2026 | Health Issues |
| MADRIGAL PHARMACEUTICALS, INC. | CROSSROADS STRATEGIES, LLC | Q3 2026 | Medicare/Medicaid, Health Issues |
| LIFESCIENCE LOGISTICS | CROSSROADS STRATEGIES, LLC | Q3 2026 | Medical/Disease Research/Clinical Labs, Health Issues, Budget/Appropriations |
| HALEON US HOLDINGS LLC | CROSSROADS STRATEGIES, LLC | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| GINKGO BIOWORKS, INC. | CROSSROADS STRATEGIES, LLC | Q3 2026 | Medical/Disease Research/Clinical Labs |
| COCA-COLA BOTTLING COMPANY UNITED, INC. | CROSSROADS STRATEGIES, LLC | Q3 2026 | Agriculture, Beverage Industry, Trade (domestic/foreign) |
| EPILEPSY FOUNDATION OF AMERICA | CROSSROADS STRATEGIES, LLC | Q3 2026 | Taxation/Internal Revenue Code, Health Issues |
| CENTERSTONE | CROSSROADS STRATEGIES, LLC | Q3 2026 | Health Issues |
| BLINK HEALTH, INC. | CROSSROADS STRATEGIES, LLC | Q3 2026 | Pharmacy |
| AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE | CROSSROADS STRATEGIES, LLC | Q3 2026 | Health Issues |
| ALTRIA CLIENT SERVICES LLC | CROSSROADS STRATEGIES, LLC | Q3 2026 | Tobacco, Taxation/Internal Revenue Code, Government Issues |
| ALKERMES, INC. | CROSSROADS STRATEGIES, LLC | Q3 2026 | Pharmacy |
| ALABAMA INSTITUTE FOR DEAF AND BLIND | CROSSROADS STRATEGIES, LLC | Q3 2026 | Budget/Appropriations |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) | CROSSROADS STRATEGIES, LLC | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| VERTEX PHARMACEUTICALS INCORPORATED | CROSSROADS STRATEGIES, LLC | Q3 2026 | Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Health Issues |
| THE BOEING COMPANY | CROSSROADS STRATEGIES, LLC | Q3 2026 | Environment/Superfund, Health Issues |
| TAKEDA PHARMACEUTICALS AMERICA, INC. | CROSSROADS STRATEGIES, LLC | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| RESEARCH!AMERICA | CROSSROADS STRATEGIES, LLC | Q3 2026 | Science/Technology, Medical/Disease Research/Clinical Labs, Budget/Appropriations |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | CROSSROADS STRATEGIES, LLC | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Medicare/Medicaid |
| MERCK & CO., INC. | CROSSROADS STRATEGIES, LLC | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| KLASKO IMMIGRATION LAW PARTNERS, LLP ON BEHALF OF INTEALTH | CROSSROADS STRATEGIES, LLC | Q3 2026 | Health Issues, Homeland Security, Immigration |
| KIDNEY CARE PARTNERS | CROSSROADS STRATEGIES, LLC | Q3 2026 | Medicare/Medicaid, Health Issues |
| EISAI, INC. | CROSSROADS STRATEGIES, LLC | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| SQUARE 407 LP | CROSSROADS STRATEGIES, LLC | Q1 2026 | Real Estate/Land Use/Conservation |
| APNIMED, INC. | CROSSROADS STRATEGIES, LLC | Q1 2026 | Medicare/Medicaid |
| BRISTOL-MYERS SQUIBB | CROSSROADS STRATEGIES, LLC | Q4 2025 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| MICRON TECHNOLOGY, INC. | CROSSROADS STRATEGIES, LLC | Q3 2025 | Science/Technology, Taxation/Internal Revenue Code, Manufacturing |
| DATA CENTER COALITION | CROSSROADS STRATEGIES, LLC | Q3 2025 | Computer Industry |
| ADVOCATES FOR COMMUNITY HEALTH | CROSSROADS STRATEGIES, LLC | Q3 2025 | Health Issues |
| ARRAY TECHNOLOGIES, INC. | CROSSROADS STRATEGIES, LLC | Q3 2025 | Energy/Nuclear |
| STRATA CLEAN ENERGY, LLC | CROSSROADS STRATEGIES, LLC | Q3 2025 | Energy/Nuclear |
| SOLV ENERGY, LLC | CROSSROADS STRATEGIES, LLC | Q3 2025 | Energy/Nuclear |
| EDF POWER SOLUTIONS DEVELOPMENT, INC. | CROSSROADS STRATEGIES, LLC | Q3 2025 | Energy/Nuclear |
| INDIVIOR INC. | CROSSROADS STRATEGIES, LLC | Q3 2025 | Medicare/Medicaid, Pharmacy |
| FOUNTAIN HOUSE | CROSSROADS STRATEGIES, LLC | Q3 2025 | Health Issues |
| COALITION FOR 1099-K FAIRNESS | CROSSROADS STRATEGIES, LLC | Q3 2025 | Taxation/Internal Revenue Code |
| VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA AG | CROSSROADS STRATEGIES, LLC | Q2 2025 | Medicare/Medicaid, Health Issues |
| NOVAVAX, INC. | CROSSROADS STRATEGIES, LLC | Q2 2025 | Trade (domestic/foreign), Health Issues, Budget/Appropriations |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 31 | 1 |
| 2025 | 38 | 1 |
| Year | Items | Total |
|---|---|---|
| 2026 | 5 | $4K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Cheryl Lynn Jaeger. See the Capitol Clarity rankings and method.